U.S. Health Care REITs Stock News

Alamar Biosciences (NasdaqGS:ALMR) doubled its revenue in Q1 2026. The company launched two new products aimed at neurodegenerative disease research. Alamar completed an IPO in 2026 to support its next phase of growth. Alamar Biosciences operates in the life sciences tools and diagnostics space, where demand for more precise protein and biomarker measurement has been a key theme for researchers and drug developers. The new products focused on neurodegenerative disease research sit in an...

Why the upcoming TN-401 data matters for Tenaya Therapeutics stock Tenaya Therapeutics (TNYA) is drawing attention as investors look ahead to new clinical safety and efficacy data for TN-401, its gene therapy for PKP2-associated arrhythmogenic right ventricular cardiomyopathy, at the ASGCT 2026 meeting. This late breaking oral presentation, together with additional abstracts on Tenaya’s gene therapy and gene editing programs, gives you fresh information to evaluate the company’s pipeline...

Sarepta Therapeutics (NasdaqGS:SRPT) is progressing its small interfering RNA (siRNA) candidates SRP-1001 and SRP-1003, with early data viewed as encouraging. The company is seeking to transition AMONDYS 45 and VYONDYS from accelerated to traditional FDA approvals through recent regulatory submissions. These updates come as Sarepta refines its commercial focus beyond gene therapy Elevidys, which continues to face regulatory and commercial complexity. Sarepta Therapeutics focuses on rare...

This article examines whether Energizer Holdings, at US$18.56, could be a bargain or a value trap, and explains what the current share price might be implying. The stock has recently seen mixed returns, with an 11.1% gain over the last 30 days but declines of 5.2% over 7 days, 6.9% year to date, and 11.5% over 1 year, extending to 39.8% over 3 years and 52.2% over 5 years. Recent coverage has focused on how Energizer Holdings fits into the broader household products sector, as investors...

AdvanSix (ASIX) closed out FY 2025 with Q4 revenue of US$359.9 million and a basic EPS loss of US$0.10. The trailing twelve months show EPS of US$1.83 on revenue of about US$1.5 billion. Over recent periods, revenue has moved from US$329.1 million in Q4 2024 to US$410.0 million in Q2 2025. Quarterly EPS has ranged from a small profit of US$0.01 in Q4 2024 to a high of US$1.17 in Q2 2025, giving investors a mix of profitable quarters and losses at the year end. With net profit margin at 3.2%...

AGI (NYSE:AGBK) has filed a substantial Shelf Registration tied to an Employee Stock Ownership Plan for a large block of Class A common shares. The filing outlines a framework for issuing ESOP related shares over time, which can influence the company’s capital structure and employee ownership levels. AGI, trading at $7.39, has had mixed recent performance, with the stock up 4.2% over the past week and 9.5% over the past month, while showing a 31.3% decline year to date. The new ESOP related...

If you are wondering whether American States Water at around US$76.84 is priced fairly or offering value, it helps to step back and look at what the recent share performance and fundamentals are signaling. Over the short term the stock is up 2.1% over the last week and is roughly flat over the past month with a 0.1% decline, while year to date it is up 6.3% and the 1 year return sits at a 1.8% decline. These moves come as investors continue to react to company specific developments and the...

Zai Lab (NasdaqGM:ZLAB) reported new clinical data from its global oncology and immunology pipeline, including intracranial response data for zoci in small cell lung cancer. The company is preparing to launch KarXT in China for schizophrenia in the next quarter. Management highlighted these pipeline and launch updates while also flagging near term revenue pressure. Zai Lab focuses on developing and commercializing medicines in oncology and immunology, as well as central nervous system...

Digi International acquired Jolt Software and Particle Industries, reshaping its Internet of Things (IoT) offering. The company reports that these deals, combined with organic growth, have lifted annual recurring revenue (ARR) by 50%. Management highlights strong cash flow as a key support for integrating these acquisitions into the existing business. Digi International (NasdaqGS:DGII) is drawing fresh attention as it leans harder into IoT platforms and recurring software revenue. The stock...

Main Street Capital (MAIN) has wrapped up FY 2025 with fourth quarter revenue of US$145.5 million and basic EPS of US$1.46. This sets the tone for a year in which trailing twelve month revenue reached US$566.4 million and EPS was US$5.52. Over recent periods, the company has reported quarterly revenue ranging between US$137.0 million and US$145.5 million, while basic EPS has moved between US$1.31 and US$1.46. Trailing net income for the year was US$493.4 million, as investors weigh those...

Gran Tierra Energy (NYSEAM:GTE) has wrapped up FY 2025 with fourth quarter revenue of US$132.6 million and a basic EPS loss of US$3.99, alongside a full year trailing revenue base of US$596.7 million and a trailing basic EPS loss of US$5.45. Over recent periods, the company has seen quarterly revenue range from US$147.0 million to US$170.5 million. Basic EPS has moved between a small profit of US$0.04 in late 2024 and losses including US$0.54 in the first quarter of 2025, setting up an...

Wondering if Matador Resources at around US$55.57 is offering solid value or asking too much for its growth story? This article walks through the key signals to help you judge whether the current price looks appealing. The stock has pulled back with a 12.4% decline over the last 7 days and a 13.8% decline over the last 30 days, even though the year to date return sits at 28.2% and the 1 year return at 35.3%. Recent coverage has focused on Matador Resources in the context of broader energy...

NI Holdings (NODK) just closed out FY 2025 with Q4 total revenue of US$61.0 million and a basic EPS loss of US$0.15, alongside a net loss of US$3.2 million, putting margins firmly under pressure. Over recent quarters, total revenue has moved from US$73.9 million in Q4 2024 to US$71.4 million in Q1 2025 and US$76.1 million in Q2 2025 before landing at US$61.0 million in Q4 2025, while EPS has swung from a profit of US$0.47 in Q4 2024 to a loss of US$0.57 in Q2 2025 and a loss of US$0.15 in the...

Sharplink (NasdaqCM:SBET) has wrapped up FY 2025 with Q4 revenue of US$15.8 million and basic EPS of a US$3.51 loss, against a backdrop of trailing twelve month revenue of US$28.1 million and basic EPS of a US$7.37 loss. Over recent quarters, the company has seen quarterly revenue move from US$0.7 million in Q1 2025 to US$10.8 million in Q3 2025 and then US$15.8 million in Q4 2025, while EPS shifted from a US$1.73 loss in Q1 to EPS of US$0.70 in Q3 and back to a US$3.51 loss in Q4. This puts...

Investors may be wondering whether Huron Consulting Group at around US$124.78 is starting to look attractive, or if the stock price still reflects too much optimism. The share price has slipped by about 4.5% over the past week and 5.2% over the past month, adding to a 27.1% decline year to date and an 18.0% return over the last year. This contrasts with the 3-year and 5-year returns, which stand at 54.7% and 126.4% respectively. These recent moves sit against a backdrop of ongoing interest...

Esperion Therapeutics (ESPR) closed out FY 2025 with fourth quarter revenue of US$168.4 million and basic EPS of US$0.26, alongside trailing twelve month revenue of US$403.1 million and a basic EPS loss of US$0.11. Over recent quarters the company has seen revenue move from US$69.1 million in Q4 2024 to US$168.4 million in Q4 2025, while quarterly EPS shifted from a loss of US$0.11 in Q4 2024 to EPS of US$0.26 in Q4 2025. This sets up a results season in which investors will be weighing how...

If you are wondering whether Gilat Satellite Networks at around US$18.84 is priced for opportunity or disappointment, the starting point is to understand what the current valuation is really implying. The stock has posted returns of 2.1% over the last 7 days and 2.2% over the last 30 days, with year to date returns of 40.5% and a 1 year return of 189.0%, alongside a 3 year return of 243.2% and a 5 year return of 119.8%. Recent news flow around Gilat Satellite Networks has focused on its...

Wondering if Aptiv's current share price reflects its true worth, or if the recent swings are masking a clearer story about value. Aptiv closed at US$57.11, with returns of a 5.2% decline over 7 days, a 1.9% decline over 30 days, a 27.2% decline year to date, but a 10.3% gain over the past year, which can leave the stock looking quite different depending on the time frame you focus on. Those mixed returns sit against a backdrop of ongoing attention on Aptiv as an auto components supplier, as...

Geospace Technologies (GEOS) opened Q1 2026 with revenue of US$25.6 million and a basic EPS loss of US$0.76, alongside a trailing twelve month basic EPS loss of US$2.17 on revenue of US$99.2 million. Over recent quarters the company has reported revenue between US$18.0 million and US$37.2 million, while EPS has ranged from a profit of US$0.66 per share in Q1 2025 to several loss-making quarters since. For investors, that mix of fluctuating topline and persistent losses keeps the attention on...

Janus Henderson Group (JHG) closed out FY 2025 with fourth quarter revenue of US$1.1 billion and basic EPS of US$2.64, capping a trailing twelve month net income of US$798.3 million on basic EPS of US$5.25. Over the past year, total revenue has moved from US$2.5 billion on trailing basic EPS of US$2.57 to US$3.1 billion on trailing basic EPS of US$5.25, alongside an improvement in net profit margin from 16.1% to 25.8%. This puts earnings quality front and center for investors assessing the...

Assertio Holdings (ASRT) closed out FY 2025 with Q4 revenue of US$13.5 million and basic EPS of a US$1.86 loss, alongside a trailing twelve month revenue base of US$118.7 million and basic EPS of a US$4.74 loss. Over the past year, quarterly revenue has moved between US$26.5 million and US$49.5 million, while quarterly basic EPS has ranged from a US$2.56 loss to US$1.78, leaving investors focused on how these shifts are feeding through to underlying margins. See our full analysis for Assertio...

SIFCO Industries (SIF) opened Q1 2026 with total revenue of US$24.0 million and net income of US$1.8 million, translating to basic EPS of US$0.29 for the quarter. The company has seen quarterly revenue move from US$21.7 million in Q4 2024 to US$20.9 million in Q1 2025 and then to US$24.0 million in Q1 2026. Basic EPS shifted from a loss of US$0.25 in Q4 2024 and US$0.40 in Q1 2025 to a profit of US$0.29 in the latest period. This sets up an earnings season in which investors are likely to...

Token Cat (TC) has just posted its H1 2025 numbers, with revenue of C¥19.8 million and a net income loss of C¥0.7 million, translating to basic EPS of C¥5.74 loss per share, while trailing 12 month figures show revenue of C¥36.6 million and a net loss of C¥148.0 million, or C¥1,200.49 loss per share. Over recent half year periods the company has seen revenue move from C¥32.3 million in H1 2024 to C¥16.9 million in H2 2024 and then to C¥19.8 million in H1 2025. Over the same periods, EPS...

Afya (NasdaqGS:AFYA) reports revenue and EBITDA growth, highlighting resilient financial performance in its latest earnings update. The Medical Practice Solutions segment faces pressure from declining active payers and stronger competition from AI driven tools. These developments point to a mixed picture for Afya, with solid headline results and emerging challenges beneath the surface. Afya operates across medical education and healthcare services in Brazil, and its latest report underlines...